We’re always interested in current research around breast cancer treatments, and we definitely perked up when we heard Avastin was pulled from the FDA approval track for treatment of metastatic breast cancer. This Q&A posted to the blog, Take As Directed, is one of the best we’ve seen that review the decision and discuss it in a way that is understandable.
Excellent FDA Q&A for Patients Regarding Avastin Breast Cancer Withdrawal | Take As Directed.
Advertisement
